ANDA 71426, held by Teva Parenteral Medicines. Vincristine Sulfate.
As of Nov 21, 2026, ANDA 71426 (Vincasar Pfs), held by Teva Parenteral Medicines, was first approved by FDA on Jul 17, 1987, with 18 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 17, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Vincasar Pfs1MG/ML · injectable;injection | Vincristine Sulfate | Discontinued |
| May 17, 1999 | Supplement 23Labeling | Approved | None posted |
| Nov 7, 1995 | Supplement 22Labeling | Approved | None posted |
| Jul 8, 1993 | Supplement 17Labeling | Approved | None posted |
| Jul 8, 1993 | Supplement 16Manufacturing | Approved | None posted |
| Mar 5, 1993 | Supplement 21Labeling | Approved | None posted |
| Nov 13, 1992 | Supplement 20Labeling | Approved | None posted |
| Sep 17, 1992 | Supplement 19Labeling | Approved | None posted |
| Aug 21, 1992 | Supplement 18Manufacturing | Approved | None posted |
| Nov 25, 1991 | Supplement 13Labeling | Approved | None posted |
| Mar 4, 1991 | Supplement 6Manufacturing | Approved | None posted |
| Jan 29, 1991 | Supplement 12Labeling | Approved | None posted |
| Feb 21, 1989 | Supplement 9Manufacturing | Approved | None posted |
| Feb 21, 1989 | Supplement 4Labeling | Approved | None posted |
| Feb 21, 1989 | Supplement 2Manufacturing | Approved | None posted |
| Dec 23, 1988 | Supplement 10Labeling | Approved | None posted |
| Jul 27, 1988 | Supplement 8Manufacturing | Approved | None posted |
| Jul 27, 1988 | Supplement 7Manufacturing | Approved | None posted |
| Mar 24, 1988 | Supplement 5Labeling | Approved | None posted |
| Jul 17, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters